In HF with mitral regurgitation, adding transcatheter mitral valve repair to medical therapy improved renal outcomes at 2 y.
Where this comes from
- Record sourced from PubMed, PMID 35667071.
- Also identified by DOI 10.7326/J22-0037.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Beohar N, Ailawadi G, Kotinkaduwa LN, et al. <b>Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial.</b> Eur Heart J. 2022;43:1639-48. 35134897.
Medical subject headings
- Heart Failure
- Heart Valve Prosthesis Implantation
- Mitral Valve Insufficiency